GSK Alli Weight Loss Product Recall [US]

US FDA RecallUS/Silver Spring: GlaxoSmithKline (GSK) Consumer Healthcare recalls all Alli Weight Loss Products from US and Puerto Rico retailers due to product tampering hazard. FDA: - AlliWeightLossProducts

Direct link:

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Drugs are subject to this recall:

  • Alli Weight Loss Products sold by US and Puerto Rico retailers

According to the FDA, GlaxoSmithKline has received multiple inquiries from consumers in seven states about bottles of Alli that contained tablets and capsules that were not Alli. A range of tablets and capsules of various shapes and colors were reported to be found inside bottles. Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic. These tampered products were purchased in retail stores.

Alli is a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat”. It is packaged in a labeled bottle that has an inner foil seal imprinted with the words, “Sealed for Your Protection”. Consumers should confirm any Alli in their possession matches this description.


Recalls Direct RIN: 3300-2014
About the Recalls Direct service:
Visit the Living Safely site:
E. & O. E.

☞ Want to e-mail or share this recall? Simply use the “Share this” options below.
☞ Is this recall relevant to you? Click on the “Like this” button below.


%d bloggers like this: